Get started
Author

Ruben J M Mijnster

Observed names: Mijnster, Ruben, RJ Mijnster, Ruben J. M. Mijnster, Ruben J.M. Mijnster, Ruben Mijnster
ORCID: 0009-0006-2528-4726
Observed ORCID: 0009-0006-2528-4726
OpenAlex ID: A5116055918
Lipid Lowering Therapy Utilization and Lipid Goal Attainment in Women
2025 · Julie A. E. van Oortmerssen, Janneke W. C. M. Mulder, et al. · Current Atherosclerosis Reports · 17
PDF
Efficacy and safety of PCSK9 monoclonal antibodies in older patients: A real-world registry
2025 · Ruben J.M. Mijnster, Janneke W.C.M. Mulder, et al. · Atherosclerosis · 4
PDF
Patient perspectives on statin intolerance, attribution of the nocebo effect and use of N=1-interventions: a qualitative focus group study
2025 · Ruben J.M. Mijnster, Marte F. van der Bijl, et al. · Atherosclerosis · 3
New insights into statin-intolerance: biopsychosocial differences, medication beliefs, trust in healthcare, and treatment decisions in statin-intolerant vs. statin-tolerant patients
2026 · Ruben J M Mijnster, Neivyn Shaheen, et al. · European Journal of Preventive Cardiology
N=1-studies in Statin-intolerance; Objectifying Nocebo Effects (nisone): a Protocol for a Randomized Controlled Trial Assessing the Implementability of N=1-studies to Promote the Use of Statins
2026 · Ruben J.M. Mijnster, Jeanine Roeters Van Lennep, et al. · Atherosclerosis
Differences in Biopsychosocial Characteristics Between Patients Who Are Statin-intolerant and Statin-tolerant: a Cross-sectional Survey Study
2026 · Ruben J.M. Mijnster, Neivyn Shaheen, et al. · Atherosclerosis
"i Don't Trust Statins": a Cross-sectional Survey Study Comparing Medication Beliefs, Factors Influencing Treatment Decisions and Healthcare Trust in Patients Who Are Statin-intolerant Vs. Statin-tolerant
2026 · Ruben J.M. Mijnster, Neivyn Shaheen, et al. · Atherosclerosis
Statin-associated Muscle Symptoms Attributable to Statin-use as Determined by N=1-trials and Cross-over Randomized Controlled Trials: a Systematic Review and Meta-analysis
2026 · Ruben J.M. Mijnster, Maud Herkströter, et al. · Atherosclerosis
Challenges in assessing statin-associated adverse events
2026 · Marte F van der Bijl, Ruben J M Mijnster, et al. · The Lancet
N=1-studies In Statin-intolerance; Objectifying Nocebo Effects (NISONE): a study protocol for a randomised controlled trial assessing the implementability of N=1-studies to promote the use of statins
2026 · Ruben Mijnster, Jeanine Roeters van Lennep, et al. · BMJ Open
PDF
Views on lipid-lowering medication and treatment decisions among statin intolerant patients and patients using statins who receive PCSK9 inhibitors
2025 · Mijnster, Ruben, Mulder, Janneke W. C. M., et al. · EUR Research Repository (Erasmus University Rotterdam)
Nocebo-effect bij intolerantie voor statinen
2025 · ML Herkströter, RJ Mijnster · Geneesmiddelenbulletin
PDF
Nocebo effect in statin intolerance
2025 · ML Herkströter, RJ Mijnster · Geneesmiddelenbulletin
Works count: 13
Citation count: 24
H-index: 3
I10-index: 1
Year
Topic
Type